{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T21:06:02Z","timestamp":1771621562301,"version":"3.50.1"},"reference-count":62,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T00:00:00Z","timestamp":1605657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013409","name":"Sistema General de Regal\u00edas de Colombia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009543","name":"Pontificia Universidad Javeriana","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007637","name":"Departamento Administrativo de Ciencia, Tecnolog\u00eda e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007637","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.584959","type":"journal-article","created":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T04:29:39Z","timestamp":1605673779000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":30,"title":["An Immunomodulatory Gallotanin-Rich Fraction From Caesalpinia spinosa Enhances the Therapeutic Effect of Anti-PD-L1 in Melanoma"],"prefix":"10.3389","volume":"11","author":[{"given":"Paola","family":"Lasso","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandra","family":"Gomez-Cadena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Urue\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alena","family":"Donda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amaia","family":"Martinez-Usatorre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso","family":"Barreto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susana","family":"Fiorentino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,11,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12916-016-0623-5","article-title":"Cancer immunotherapy: the beginning of the end of cancer","volume":"14","author":"Farkona","year":"2016","journal-title":"BMC Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3626","article-title":"The secret ally: immunostimulation by anticancer drugs","volume":"11","author":"Galluzzi","year":"2012","journal-title":"Nat Rev Drug Discovery"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.13040\/IJPSR.0975-8232.6(10).4103-12","article-title":"Medicinal Plants: Their Use in Anticancer Treatment","volume":"6","author":"Greenwell","year":"2015","journal-title":"Int J Pharm Sci Res"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2015.03.001","article-title":"Immune checkpoint blockade: a common denominator approach to cancer therapy","volume":"27","author":"Topalian","year":"2015","journal-title":"Cancer Cell"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2011.12.009","article-title":"Targeting the PD-1\/B7-H1(PD-L1) pathway to activate anti-tumor immunity","volume":"24","author":"Topalian","year":"2012","journal-title":"Curr Opin Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers11101472","article-title":"Current Perspectives in Cancer Immunotherapy","author":"Christofi","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/science.aax0182","article-title":"Neoadjuvant checkpoint blockade for cancer immunotherapy","volume":"367","author":"Topalian","year":"2020","journal-title":"Science"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/nature13954","article-title":"PD-1 blockade induces responses by inhibiting adaptive immune resistance","volume":"515","author":"Tumeh","year":"2014","journal-title":"Nature."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N Engl J Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1809615","article-title":"Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer","volume":"379","author":"Schmid","year":"2018","journal-title":"N Engl J Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e2243","DOI":"10.1038\/cddis.2016.134","article-title":"Immune-system-dependent anti-tumor activity of a plant-derived polyphenol rich fraction in a melanoma mouse model","volume":"7","author":"Gomez-Cadena","year":"2016","journal-title":"Cell Death Dis"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1177\/1534735415596425","article-title":"Multifunctional T Lymphocytes Generated After Therapy With an Antitumor Gallotanin-Rich Normalized Fraction Are Related to Primary Tumor Size Reduction in a Breast Cancer Model","volume":"14","author":"Urue\u00f1a","year":"2015","journal-title":"Integr Cancer Ther"},{"key":"B13","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/1472-6882-13-74","article-title":"Gallotannin-rich Caesalpinia spinosa fraction decreases the primary tumor and factors associated with poor prognosis in a murine breast cancer model","volume":"13","author":"Urue\u00f1a","year":"2013","journal-title":"BMC Complement Altern Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/S0944-7113(00)80085-9","article-title":"Chemopreventive effects of sage oil on skin papillomas in mice","volume":"7","author":"Gali-Muhtasib","year":"2000","journal-title":"Phytomedicine"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1080\/01635589409514337","article-title":"Prevention of photocarcinogenesis and UV-induced immunosuppression in mice by topical tannic acid","volume":"22","author":"Gensler","year":"1994","journal-title":"Nutr Cancer"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-005-4819-9","article-title":"Radiation protection by Terminalia chebula: some mechanistic aspects","volume":"277","author":"Gandhi","year":"2005","journal-title":"Mol Cell Biochem"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1021\/np50086a002","article-title":"Antitumor agents, 129. Tannins and related compounds as selective cytotoxic agents","volume":"55","author":"Kashiwada","year":"1992","journal-title":"J Nat Prod"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2004.04.026","article-title":"Phenolic acid derivatives with potential anticancer properties\u2013a structure-activity relationship study. Part 1: methyl, propyl and octyl esters of caffeic and gallic acids","volume":"12","author":"Fiuza","year":"2004","journal-title":"Bioorg Med Chem"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1142\/S0192415X16500956","article-title":"Standardized Extract from Caesalpinia spinosa is Cytotoxic Over Cancer Stem Cells and Enhance Anticancer Activity of Doxorubicin","volume":"44","author":"Sandoval","year":"2016","journal-title":"Am J Chin Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00356","article-title":"Prophylactic vs. Therapeutic Treatment With P2Et Polyphenol-Rich Extract Has Opposite Effects on Tumor Growth","volume":"8","author":"Lasso","year":"2018","journal-title":"Front Oncol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1472-6882-12-38","article-title":"A gallotannin-rich fraction from Caesalpinia spinosa (Molina) Kuntze displays cytotoxic activity and raises sensitivity to doxorubicin in a leukemia cell line","volume":"12","author":"Casta\u00f1eda","year":"2012","journal-title":"BMC Complement Altern Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3892\/or.2017.5399","article-title":"The JAK\/STAT pathway is involved in the upregulation of PD-L1 expression in pancreatic cancer cell lines","volume":"37","author":"Doi","year":"2017","journal-title":"Oncol Rep"},{"key":"B23","article-title":"Vascularization and tumour volume estimations of solitary liver tumours in rats","volume":"72","author":"Carlsson","year":"1983","journal-title":"Ann Chir Gynaecol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-1759(01)00359-3","article-title":"A novel flow cytometric assay for quantitation and multiparametric characterization of cell-mediated cytotoxicity","volume":"253","author":"Lecoeur","year":"2001","journal-title":"J Immunol Methods"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1177\/1534735419848047","article-title":"Breast Tumor Cells Highly Resistant to Drugs Are Controlled Only by the Immune Response Induced in an Immunocompetent Mouse Model","volume":"18","author":"Lasso","year":"2019","journal-title":"Integr Cancer Ther"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20131916","article-title":"PD-L1 is a novel direct target of HIF-1alpha, and its blockade under hypoxia enhanced MDSC-mediated T cell activation","volume":"211","author":"Noman","year":"2014","journal-title":"J Exp Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"127ra37","DOI":"10.1126\/scitranslmed.3003689","article-title":"Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape","volume":"4","author":"Taube","year":"2012","journal-title":"Sci Transl Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0161779","article-title":"Preclinical Development of Ipilimumab and Nivolumab Combination Immunotherapy: Mouse Tumor Models, In Vitro Functional Studies, and Cynomolgus Macaque Toxicology","volume":"11","author":"Selby","year":"2016","journal-title":"PloS One"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.8130","article-title":"The comparison of outcomes from tyrosine kinase inhibitor monotherapy in second- or third-line for advanced non-small-cell lung cancer patients with wild-type or unknown EGFR status","volume":"7","author":"Bronte","year":"2016","journal-title":"Oncotarget."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1172\/JCI96113","article-title":"Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade-mediated tumor regression","volume":"128","author":"Lin","year":"2018","journal-title":"J Clin Invest"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/jir.2014.0026","article-title":"The role of cytokines in breast cancer development and progression","volume":"35","author":"Esquivel-Velazquez","year":"2015","journal-title":"J Interferon Cytokine Res"},{"key":"B32","article-title":"Concentration of interleukin-6 (IL-6), interleukin-8 (IL-8) and interleukin-10 (IL-10) in blood serum of breast cancer patients","volume":"48","author":"Kozlowski","year":"2003","journal-title":"Rocz Akad Med Bialymst"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.2000.1402","article-title":"Soluble interleukin-2 receptor, intercellular adhesion molecule-1 and interleukin-10 serum levels in patients with melanoma","volume":"83","author":"Boyano","year":"2000","journal-title":"Br J Cancer"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-15-0149","article-title":"Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness","volume":"4","author":"Miller","year":"2016","journal-title":"Cancer Immunol Res"},{"key":"B35","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41392-018-0022-9","article-title":"The intracellular signalosome of PD-L1 in cancer cells","volume":"3","author":"Escors","year":"2018","journal-title":"Signal Transduct Target Ther"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2014.04.010","article-title":"Programmed death-1 pathway in cancer and autoimmunity","volume":"153","author":"Pedoeem","year":"2014","journal-title":"Clin Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2018.4512","article-title":"Upregulation of PDL1 expression by resveratrol and piceatannol in breast and colorectal cancer cells occurs via HDAC3\/p300mediated NFkappaB signaling","volume":"53","author":"Lucas","year":"2018","journal-title":"Int J Oncol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S130653","article-title":"Bisdemethoxycurcumin in combination with alpha-PD-L1 antibody boosts immune response against bladder cancer","volume":"10","author":"Shao","year":"2017","journal-title":"Onco Targets Ther"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms20071714","article-title":"Polyphenols as Immunomodulatory Compounds in the Tumor Microenvironment: Friends or Foes","volume":"20","author":"Focaccetti","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B40","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s13046-018-0929-6","article-title":"Apigenin suppresses PD-L1 expression in melanoma and host dendritic cells to elicit synergistic therapeutic effects","volume":"37","author":"Xu","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.22365","article-title":"Pan-cancer analysis of copy number changes in programmed death-ligand 1 (PD-L1, CD274) - associations with gene expression, mutational load, and survival","volume":"55","author":"Budczies","year":"2016","journal-title":"Genes Chromosomes Cancer"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.2980","article-title":"PD-1 pathway inhibitors: the next generation of immunotherapy for advanced melanoma","volume":"6","author":"Luke","year":"2015","journal-title":"Oncotarget"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/nm1517","article-title":"Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma","volume":"13","author":"Parsa","year":"2007","journal-title":"Nat Med"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2008.384","article-title":"PI(3) kinase is associated with a mechanism of immunoresistance in breast and prostate cancer","volume":"28","author":"Crane","year":"2009","journal-title":"Oncogene."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-56246-9_18","article-title":"[MiR-140-3p Downregulation in Association with PDL-1 Overexpression in Many Cancers: A Review from the Literature Using Predictive Bioinformatics Tools]","volume":"988","author":"Kapodistrias","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2019.12.008","article-title":"Natural products targeting the PI3K-Akt-mTOR signaling pathway in cancer: A novel therapeutic strategy","author":"Tewari","year":"2019","journal-title":"Semin Cancer Biol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1802166115","article-title":"D. S. Chen and P. S. Hegde: Differential regulation of PD-L1 expression by immune and tumor cells in NSCLC and the response to treatment with atezolizumab (anti-PD-L1)","volume":"115","author":"Kowanetz","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1016\/j.cell.2016.11.022","article-title":"Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade","volume":"167","author":"Benci","year":"2016","journal-title":"Cell"},{"key":"B49","doi-asserted-by":"publisher","first-page":"5241","DOI":"10.1038\/ncomms6241","article-title":": Metastasis is regulated via microRNA-200\/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression","volume":"5","author":"Chen","year":"2014","journal-title":"Nat Commun"},{"key":"B50","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1177\/0300985811429314","article-title":"Immunological variation between inbred laboratory mouse strains: points to consider in phenotyping genetically immunomodified mice","volume":"49","author":"Sellers","year":"2012","journal-title":"Vet Pathol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1084\/jem.181.2.713","article-title":"T cell genetic background determines default T helper phenotype development in vitro","volume":"181","author":"Hsieh","year":"1995","journal-title":"J Exp Med"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20090207","article-title":"IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway","volume":"206","author":"Wang","year":"2009","journal-title":"J Exp Med"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2012.1036","article-title":"Interleukin-17, produced by lymphocytes, promotes tumor growth and angiogenesis in a mouse model of breast cancer","volume":"6","author":"Du","year":"2012","journal-title":"Mol Med Rep"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/314620","article-title":"Th17 Cell Plasticity and Functions in Cancer Immunity","volume":"2015","author":"Guery","year":"2015","journal-title":"BioMed Res Int"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1203141","article-title":"Increased Th17 cells in the tumor microenvironment is mediated by IL-23 via tumor-secreted prostaglandin E2","volume":"190","author":"Qian","year":"2013","journal-title":"J Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-4087","article-title":"Interleukin-23 and interleukin-27 exert quite different antitumor and vaccine effects on poorly immunogenic melanoma","volume":"66","author":"Oniki","year":"2006","journal-title":"Cancer Res"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02100","article-title":"The Antitumor Activity of Combinations of Cytotoxic Chemotherapy and Immune Checkpoint Inhibitors Is Model-Dependent","volume":"9","author":"Grasselly","year":"2018","journal-title":"Front Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.30.946","article-title":"Assessment by survival analysis of the radioprotective properties of propolis and its polyphenolic compounds","volume":"30","author":"Orsolic","year":"2007","journal-title":"Biol Pharm Bull"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1038\/nri3175","article-title":"Coordinated regulation of myeloid cells by tumours","volume":"12","author":"Gabrilovich","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-2528","article-title":"Polyphenon [corrected] E enhances the antitumor immune response in neuroblastoma by inactivating myeloid suppressor cells","volume":"19","author":"Santilli","year":"2013","journal-title":"Clin Cancer Res"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-11-0247","article-title":"Curcumin induces the differentiation of myeloid-derived suppressor cells and inhibits their interaction with cancer cells and related tumor growth","volume":"5","author":"Tu","year":"2012","journal-title":"Cancer Prev Res (Phila)"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2015.165","article-title":"Curcumin Micelles Remodel Tumor Microenvironment and Enhance Vaccine Activity in an Advanced Melanoma Model","volume":"24","author":"Lu","year":"2016","journal-title":"Mol Ther"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.584959\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T04:29:42Z","timestamp":1605673782000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.584959\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,18]]},"references-count":62,"alternative-id":["10.3389\/fimmu.2020.584959"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.584959","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,18]]},"article-number":"584959"}}